CTRI/2021/06/034218
Completed
未知
Effectiveness of a multicomponent intervention on symptom burden duringchemotherapy - MCIT
MIMS College of Nursing0 sites32 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- MIMS College of Nursing
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged 18 years or older.
- •Diagnosed with stage 1 to stage 3 of Breast and Colorectal cancer
- •Starting their first treatment with IV chemotherapy requiring outpatient hospital visits
- •Willing to participate in the study and give voluntary consent.
- •Able to speak, read and write in Malayalam.
Exclusion Criteria
- •Metastatic cases
- •Undergoing concurrent radiation and hormonal treatment.
- •Having severe cognitive/emotional issues as determined by the patientââ?¬•s treating oncologist.
- •Already received chemotherapy for their malignancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effectiveness of a multicomponent intervention to promote physical activity among Japanese remote workers: A pilot randomized controlled trialJPRN-UMIN000046638Faculty of Health and Sport Sciences, University of Tsukuba51
Not yet recruiting
Not Applicable
Multi-component program to minimize social media use and improve physical activity among school teenagers in North India.CTRI/2024/03/064621Dr. Madhu Gupta
Not yet recruiting
Not Applicable
Improving Perinatal Bereavement Support Trial (Kenya & Uganda)Mental and Behavioural DisordersPregnancy and ChildbirthPACTR202402576062416iverpool School of Tropical Medicine840
Active, not recruiting
Not Applicable
Improving perinatal bereavement support in Kenya and UgandaISRCTN10863496iverpool School of Tropical Medicine840
Not yet recruiting
Not Applicable
Effect of a multicomponent intervention to promote physical activity in adults with intellectual disabilitiesSedentary behavior1003717310024450InactivityNL-OMON56833Erasmus MC, Universitair Medisch Centrum Rotterdam200